Bristol-Myers Squibb in its $90 billion acquisition of Celgene and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen
Bristol-Myers Squibb in its defense against Starboard Value’s proxy contest opposing Bristol-Myers Squibb’s $90 billion acquisition of Celgene
Colfax Corporation in its $3.2 billion acquisition of DJO Global
Fox Corporation in its $397 million acquisition of Credible Labs
Harland Clarke Holdings in its sale of Scantron Corporation to Transom Capital Group
WellCare Health Plans in its $17.3 billion acquisition by Centene Corporation
Sentinel Capital Partners in its acquisition of New Era Technology, Inc., a technology solutions provider
The Jordan Company, L.P. in its acquisition of Vyne, a provider of software solutions for secure health information exchange and electronic healthcare communication management
